Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Strimvelis
Biotech
XyloCor hires Reinhardt as CMO to lead gene therapy programs
Reinhardt, who helped GlaxoSmithKline get a gene therapy to market, joins XyloCor to advance genetic treatments for cardiovascular diseases.
Nick Paul Taylor
Aug 7, 2019 9:13am
Orchard raises $150M for multifront late-phase gene therapy push
Aug 13, 2018 8:55am
Orchard raises $110M to bring gene therapy to market
Dec 20, 2017 3:00am
Sanofi drops Voyager’s phase 2/3 Parkinson’s gene therapy
Oct 31, 2017 8:45am
Orchard Therapeutics hires ex-PTC exec Rothera as new CEO
Aug 10, 2017 8:28am
Pfizer doubles down on gene therapy pipeline with $70M Sangamo buy-in
May 11, 2017 4:54am
